PrEP in transmasculine people
A new article in “Physician’s Weekly” titled, “Q&A: Improving PrEP Access in Transgender Men, Other Transmasculine People” interviewed two leading HIV doctors on a study they conducted to assess how HIV prevention can best be implemented in the transmasculine population.
Strangely — or maybe not so strangely — HIV prevention is not examined enough in transgender men and other assigned-female-at-birth (AFAB) individuals who choose to masculinize and decide to have sex with men.
But it’s important, and crucial, to study how the HIV prevention medicine PrEP can best be administered to make sure that all genders are feeling its full and successful effect.
Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s and 1990s.
